Cardio Diagnostics Holdings, Inc.
CDIO Healthcare Biotechnology
Cardio Diagnostics Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14,800.00, down 57.6% from fiscal 2024. In the quarter to June 2026, revenue fell 28.0%, EPS grew 47.4% and free cash flow grew 15.6%, each against the same quarter a year earlier.
Follow CDIO
Cardio Diagnostics Holdings, Inc. (CDIO) EV/Sales
As of 16 October 2026, Cardio Diagnostics Holdings, Inc. (CDIO) trades at a EV/Sales of −40.1×. Over the past ten years it has ranged from −220× (February 2026) to 985× (December 2024); the current reading is higher than 18% of that period. That is below the Biotechnology industry median of 9.2× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | −24.5× | — |
| FY2024 | 482× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 61.3× | — |
| Mar 2026 | −92.1× | — |
| Dec 2025 | −24.5× | — |
| Sep 2025 | 43.9× | — |
| 9 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| CELZ Creative Medical Technology Holdings, Inc. compare | −352× |
| CDIO Cardio Diagnostics Holdings, Inc. | −40.1× |
| CANF Can-Fite Biopharma Ltd compare | −8.6× |
| LGVN Longeveron Inc. compare | −4.2× |
| XBIO Xenetic Biosciences, Inc. compare | −0.2× |
| RVPH Reviva Pharmaceuticals Holdings, Inc. compare | n/m |
| BGMS Bio Green Med Solution, Inc. compare | 0.7× |
| PULM Pulmatrix, Inc. compare | 0.8× |
| ORGS Orgenesis Inc. compare | 15.7× |
| Biotechnology industry median | 9.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)